BOLD Diagnostics, LLC Places Fourth Place In 2016 Rice Business Plan Competition
BOLD Diagnostivs, LLC Places Fourth Place In 2016 Rice Business Plan Competition
Nearly $1.7 million awarded at world’s richest, largest student startup competition
HOUSTON – (April 16, 2016) – Bold Diagnostics, LLC from Northwestern University emerged as the fourth place startup company in the Rice Business Plan Competition (RBPC) hosted by the Rice Alliance for Technology and Entrepreneurship. The annual event is the world’s richest and largest student startup competition.
Selected by 275 judges from the investment sector as representing the best investment opportunity and taking home $128,000 in cash and prizes, Bold Diagnostics, LLC competed against 41 other competitors hailing from some of the world’s top universities.
Bold Diagnostics, Northwestern University -- fourth place and more than $128,000 in individual prizes.
Eight total prizes were awarded to the company including:
- $5,000 Rice Business Plan Competition Fourth Place Award sponsored by EY
- $25,000 Cisco Internet of Everything Innovation Challenge Prize
- $25,000 TMCx Digital Health Accelerator Prize
- $20,000 NASA Earth/Space Human Health and Performance Innovation Cash Award
- $50,000 TiE RBPC Angel Investment Prize
- $3,000 Best Written Business Plan sponsored by Palo Alto Software
- Mercury Fund Elevator Pitch Competition 4th Place Prize
- 2016 Rice Business Plan Competition Semi-Final Round Flight 21st Place Award
Bold Diagnostics, LLC is a Northwestern University startup that is developing the future of blood-pressure monitoring with an innovative platform. The company’s patent-pending technology is currently being validated through an IRB approved study at Northwestern Memorial Hospital. The team members include Northwestern University Center for Device Development (CD2) Fellows Jay Pandit, Kyle Miller, Sean Connell and Andrew Wu.
The prizes were presented tonight at a banquet at the Hilton Americas-Houston that concluded the three-day event, which began April 14.
This year’s competitors were the most diverse in the history of the competition and came from top universities around the globe. The teams were chosen from nearly 400 entrants to compete in four categories: life sciences; information technology/Web/mobile; energy/clean technology/sustainability; and other. Each team made its case in 15-minute investment pitches and a rapid-fire 60-second elevator-pitch contest on the first night of the competition.
Since the RBPC’s inception in 2001, when nine teams competed for $10,000, more than 161 competitors have gone on to successfully launch their ventures and are still in business today; another 15 have successfully sold their ventures. Past competitors have raised in excess of $1.3 billion in funding and created more than 2,000 new jobs. The 16th annual RBPC was hosted by the Rice Alliance for Technology and Entrepreneurship and the Jones School. For more information about the RBPC, visit www.ricebusinessplancompetition.com.
In today’s environment, even promising healthech innovations fail to get investments from financially motivated investors. As a result, solutions do not survive the so-called Valley of Death. There are numerous good reasons why investors choose not to invest. In many cases, it is because the innovator did not anticipate and prepare a response to a question about a particular risk. This can be traced back to the fact that innovators often fail to put themselves in an investor’s shoes. Doing so is critical to understanding why they may not invest in their solution—the “deal killers”.
National Institute of Biomedical Imaging and Bioengineering Point-of-Care Technology Research Network
This paper describes the POCTRN and the three currently funded Centers as examples of academic-based organizations that support collaborations across disciplines, institutions, and geographic regions to successfully drive innovative solutions from concept to patient care.
Healthcare commercialization programs (HCPs) are described and proposed as an option that institutions can add to their portfolio to improve translational research. In helping teams translate specifc healthcare innovations into practice, HCPs expand the skillset of investigators and enhance an institution's innovation capacity. Lessons learned are shared from configuring and delivering HCPs, which build on the fundamentals of the National Science Foundation's Innovation Corps program, to address the unique challenges in supporting healthcare innovations and innovators.
This is an ongoing, work-in-process update of CIMIT’s Clinical Impact Study (CIS). First conducted in 2009, the CIS is a self-assessment by CIMIT faculty and investigators of its project portfolio and Accelerator Program and now includes projects initiated between 1998 and 2012. The innovation portfolio, an important subset of the ways in which CIMIT helps speed innovations into patient care, represents an investment of almost $70M over 14 years. It also represents a rather unique longitudinal set of experiences from which to learn.
If ever an industry was in need of both incremental and disruptive innovation it is today's health care industry. Realizing the full potential of innovation across the spectrum of health care environments is critical to address the well-documented, emerging global crisis generated by the aging of the population, the obligation to increase access for all to the best standard of care, and the societal imperative to contain costs.
Would a carpenter be asked to manage building a new housing development? Probably not. More likely a real estate developer with the skills, experience and knowledge of the local market and trades, including carpentry, would manage such an undertaking. Good developers anticipate and address the challenges of building and selling homes. Delivering attractive appropriately priced homes on time and on budget requires that developers use their knowledge, experience, and judgment to make numerous decisions that engage the right talent at the right time to balance development risks and costs.
The Consortia for Improving Medicine with Innovation & Technology (CIMIT) was established in 1998 by four leading academic medical centers and universities in the greater Boston area to leverage the value of a consortium to improve patient care through Deep Innovation using medical technology to solve pressing unmet medical needs.